Preliminary Q1 2026: Sales & Net Profit Up, Operating Profit Down YoY
-
Q1 2026 sales: KRW 42,848M (+9.58% YoY, +3.09% QoQ), operating profit: KRW 6,804M (-15.79% YoY, +34.62% QoQ), net profit: KRW 9,498M (+30.85% YoY, +600.13% QoQ)
-
Controlling interest net profit: KRW 9,589M (+32.22% YoY, +657.03% QoQ)
-
These are preliminary figures, subject to change after external audit review
KOSDAQ Filing Information
-
Filing: Consolidated Financial Statements Basis Operating (Provisional) Results (Fair Disclosure)
-
Company: Boditech Med (206640)
-
Submission: Boditech Med Inc.
-
Receipt: 05-08-2026
-
Under KRX KOSDAQ Market Division